Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego Szpital Kliniczny Dzieciątka

The department is conducting studies on muscle-invasive bladder cancer, aiming to assess whether a novel immunotherapy combination can increase complete clinical response rates and support bladder preservation.

• Combination immunotherapy with checkpoint inhibitors
• Bladder‑sparing treatment approaches
• Evaluation of long‑term event‑free survival

Research is carried out at the Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego Szpital Kliniczny Dzieciątka, providing patients access to cutting‑edge cancer care.

Investigators are evaluating VI‑0106 (extended‑release tacroliz) as an adjunct therapy for pulmonary arterial hypertension, focusing on functional capacity, pulmonary hemodynamics, and risk marker improvement.

• Extended‑release tacrolimus formulation
• Functional outcome measures
• Hemodynamic and biomarker assessment

The trials are hosted at the same Warsaw clinical center, offering participants the opportunity to contribute to advances in PAH management.